Search results
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 15 hours agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
CDC issues update on H5N2 bird flu strain that killed Mexico man
Newsweek· 5 days agoThe U.S. Centers for Disease Control and Prevention (CDC) has issued an update on the H5N2 bird flu...
I'm an American who's lived in Spain for 4 years. I wish I knew these 10 things before I moved.
Business Insider via Yahoo News· 5 days agoI also live steps from a labyrinth of delicious restaurants and chic bars, which are generally more...
Celtics fan hoping this is the year he can finally correct inaccurate "2022 World Champions" tattoo
CBS News· 1 day agoThere's nothing like tattoo ink, to force a fan to commit to a dream, even if it isn't meant to be....
Common A/C issues during the summer and how to prevent them
FOX 7 Austin· 1 day agoWith the temperatures heating up, FOX 7 Austin checks in with a professional about how to keep your...
Man named Optimus Prime arrested for car theft in south Austin: affidavit
FOX 7 Austin· 6 days agoA man named Optimus Prime was arrested earlier this week for car theft in south Austin.
What to know about Moderna’s combined covid-flu vaccine on the horizon
Boston.com· 4 days agoModerna’s combined coronavirus-influenza shot reportedly produced a higher immune response in older...
Who won Euro 2020? How England and Italy reached final at Wembley in tournament affected by COVID-19...
Sporting News· 16 hours agoThe Euros is here and, with 24 teams taking part in this year's tournament, there are several...
COVID taught us a lot for future pandemics. Attacking Fauci doesn't make us safer.
USA TODAY Opinion via Yahoo News· 2 days agoWill we come together to save lives? While it makes some sense to use flu as the model for...
Research Analysts’ Recent Ratings Changes for Concrete Pumping (BBCP)
ETF DAILY NEWS· 4 days ago6/10/2024 – Concrete Pumping had its price target lowered by analysts at Robert W. Baird from $8.50...